Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
01 April 2024Website:
http://www.solventum.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
pre-market | 53 min agoDividend
Analysts recommendations
Institutional Ownership
SOLV Latest News
ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 at 11:30 a.m.
Solventum's Clarity precision grip attachments improve results for orthodontic patients by lowering the chances of incorrect or poorly shaped attachments.
Solventum Corporation (NYSE:SOLV) will hold its Q3 2024 Earnings Conference Call on November 7, 2024, at 4:30 PM ET. The call will feature company representatives including Kevin Moran, Bryan Hanson, and Wayde McMillan, along with analysts from various financial institutions. The operator for the call is Amy, who will assist participants throughout the session.
Solventum's revenue shows positive effects from adjusted pricing. The main reason for organic growth is the increasing demand for MedSurg products.
On Thursday, Solventum, a company that spun off from 3M, increased its yearly profit expectations due to anticipated high sales of its wound care and surgical sterilization items.
SOLV's performance in the third quarter may have been negatively affected by slow revenue growth in various markets and challenges with currency exchange rates. However, better pricing strategies could have helped reduce the impact of falling sales.
The company is likely to attract interest from private equity firms and strategic buyers looking to acquire it.
Solventum (SOLV) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.
ST. PAUL, Minn., Oct. 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) is set to announce its financial results for the third quarter of 2024 on Thursday, November 7, 2024, after the U.S. markets have closed.
ST. PAUL, Minn., Oct. 10, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) has announced that Dr. Ryan Egeland, MD, will be taking on the role of chief medical officer.
- 1(current)
What type of business is Solventum?
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
What sector is Solventum in?
Solventum is in the Healthcare sector
What industry is Solventum in?
Solventum is in the Health Information Services industry
What country is Solventum from?
Solventum is headquartered in United States
When did Solventum go public?
Solventum initial public offering (IPO) was on 01 April 2024
What is Solventum website?
https://www.solventum.com
Is Solventum in the S&P 500?
Yes, Solventum is included in the S&P 500 index
Is Solventum in the NASDAQ 100?
No, Solventum is not included in the NASDAQ 100 index
Is Solventum in the Dow Jones?
No, Solventum is not included in the Dow Jones index
When was Solventum the previous earnings report?
No data
When does Solventum earnings report?
The next expected earnings date for Solventum is 28 February 2025